Commentary on "Exploring the Phenotypic Profile of Acute Flaccid Paralysis: Insights from a Third-Level Pediatric Emergency Room". [PDF]
Hosseinpour S +4 more
europepmc +1 more source
Intestinal Mucosal Immune Responses to Novel Oral Poliovirus Vaccine Type 2 in Healthy Newborns. [PDF]
Godin A +15 more
europepmc +1 more source
Polio eradication in Africa: hard-won gains, prevailing challenges and what comes next. [PDF]
Hayes K, Touray K, Safdar N, Ahmed J.
europepmc +1 more source
Given its enhanced genetic stability, novel oral poliovirus vaccine type 2 was deployed for type 2 poliovirus outbreak responses under World Health Organization Emergency Use Listing. We evaluated the safety profile of this vaccine.
core
Safety of Sabin-Strain Inactivated Poliovirus Vaccine Administered Alone or Concomitantly with Other Vaccines: A Population-Based Post-Marketing Surveillance Study. [PDF]
Chang L +5 more
europepmc +1 more source
Monitoring the infectious titer of bOPV and the vaccine vial monitor stage at different storage temperature ranges. [PDF]
Yough MD +5 more
europepmc +1 more source
Quantifying the role of contact sampling for poliovirus detection in Nigeria. [PDF]
Ledien J +4 more
europepmc +1 more source
Progress and gaps in poliovirus immunity: Evidence from a serological survey of children aged 6-23 months in high-risk districts of Pakistan. [PDF]
Hussain I +10 more
europepmc +1 more source
Towards Global HPV Eradication: Single-Dose HPV Vaccination vs. Pseudoscience. [PDF]
Shiro R, Tsunoda I.
europepmc +1 more source

